September 2009.
Meabco has also started the enrollment of patients for its Phase I
dose-escalation trial in Thailand.
June 2009.
Meabco has initiated a Phase I dose-escalation trial in Indonesia,
in patients with advanced metastatic breast cancer. The aim is
also
to expand the trial to Thailand, Taiwan, Poland and Norway. A
total of 33 patients will be enrolled.
May 2009.
Meabco has successfully completed the manufacturing of its third
large scale pharmaceutical grade batch of BP-C1.
July 2009.
Meabco
was granted a Japanese patent on the composition of BP-C1
Jan 2009.
Meabco was granted a US patent on the
composition of BP-C1. A similar patent was granted in the EU
in 2008.
